Most Recent
Judge questions need for solicitors in Jaguar class action discovery process
A judge has questioned the need for solicitors in a class action against Jaguar to be involved in discovery of internal investigations by the car maker when a technical referee is to be appointed.
Law firm defending junior doctors class actions might get a lot busier
Victorian healthcare providers facing class actions on behalf of junior doctors have turned to one law firm to lead their defence. And that firm might be about to get a lot busier.
High Court asked to hear coverage row over Knox Grammar abuse claims
The Uniting Church has asked the High Court to weigh in after an appeals court found insurer Allianz was not on the hook for claims of abuse at exclusive Sydney private school Knox Grammar.
Port of Newcastle can’t move wharf dispute with Glencore out of state court
The Port of Newcastle has lost its bid to move a lawsuit filed by Glencore Coal over $870,000 in alleged overcharged shipping fees to the Federal Court. 
Construction PRO
Bathla wins approval for $52M Blacktown development
Developer Bathla has won approval for a 20-storey commercial tower in Blacktown, NSW following a conciliation conference with the council.
Bayer class action wants to know bill for failed case before deciding on appeal
The plaintiff in an unsuccessful class action against Bayer over its Essure contraceptive device wants to see whether she can avoid paying costs in the case before deciding on whether to appeal the loss.
Construction PRO
Project finance pro joins Clayton Utz from Baker McKenzie
Clayton Utz has snagged a partner with experience advising on financing for major projects from Baker McKenzie.
Judge shuts down Lovisa counsel’s ‘pejorative remark’ about employment class actions
A judge hearing a suit against Lovisa has questioned whether it should proceed as a class action, but shut down a 'pejorative remark' by the jewellery chain's barrister about Fair Work class actions.
Lundbeck, Sandoz end long-running Lexapro patent war
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.